UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

Combating Alzheimer's Through Sleep and Exercise

Not Applicable

Recruiting

Conditions: Dementia
Alzheimer Disease

Interventions: Device: DREEM 2 Headband
Other: Exercise Routine

First Posted Date: 2021-04-22

Last Posted Date: 2025-02-24

Lead Sponsor: University of Miami

Target Recruit Count: 30

Registration Number: NCT04855630

Locations: 🇺🇸
University of Miami Hospitals, Miami, Florida, United States

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

Phase 4

Completed

Conditions: Eye Manifestations
Ptosis, Eyelid
Conjunctiva Inflamed

Interventions: Drug: Oxymetazoline hydrochloride 0.1% ophthalmic solution
Drug: Placebo

First Posted Date: 2021-04-05

Last Posted Date: 2023-04-24

Lead Sponsor: University of Miami

Target Recruit Count: 114

Registration Number: NCT04831047

Locations: 🇺🇸
University of Miami Bascom Palmer Eye Institute, Miami, Florida, United States

Recurrent Urinary Tract Infections and the Microbiome

Terminated

Conditions: Recurrent Urinary Tract Infection

First Posted Date: 2021-04-05

Last Posted Date: 2024-05-21

Lead Sponsor: University of Miami

Target Recruit Count: 32

Registration Number: NCT04831840

Locations: 🇺🇸
Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸
University of Miami, Miami, Florida, United States

Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 2

Withdrawn

Conditions: HNSCC
Squamous Cell Carcinoma of the Larynx
Squamous Cell Carcinoma of the Oral Cavity
Squamous Cell Carcinoma of Hypopharynx
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Cemiplimab-Rwlc

First Posted Date: 2021-04-05

Last Posted Date: 2022-08-04

Lead Sponsor: University of Miami

Registration Number: NCT04831450

OAB and the Microbiome

Terminated

Conditions: Overactive Bladder
Urgency-frequency Syndrome

First Posted Date: 2021-04-05

Last Posted Date: 2024-05-21

Lead Sponsor: University of Miami

Target Recruit Count: 39

Registration Number: NCT04831801

Locations: 🇺🇸
Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸
University of Miami, Miami, Florida, United States

QOL and GI Outcomes in Malignancies

Not Applicable

Withdrawn

Conditions: Stress, Emotional
Psychological Adaptation
Psychological Adjustment

Interventions: Behavioral: Standard Education
Behavioral: Cognitive Behavioral Therapy (CBT)-based skills

First Posted Date: 2021-03-25

Last Posted Date: 2024-11-26

Lead Sponsor: University of Miami

Target Recruit Count: 60

Registration Number: NCT04815746

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Happy Older Latinos Are Active - Cognitive Decline

Not Applicable

Completed

Conditions: Cognitive Decline

Interventions: Behavioral: Happy Older Latinos are Active (HOLA)

First Posted Date: 2021-03-10

Last Posted Date: 2025-03-17

Lead Sponsor: University of Miami

Target Recruit Count: 30

Registration Number: NCT04791709

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Sleep & Postoperative Delirium in Hispanic/ Latino Patients After Cardiothoracic Surgery

Completed

Conditions: Delirium in Old Age
Sleep Disturbance
Circadian Rhythm Sleep Disorder

First Posted Date: 2021-03-08

Last Posted Date: 2022-04-29

Lead Sponsor: University of Miami

Target Recruit Count: 14

Registration Number: NCT04786899

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Patient Performance and Acceptance of Virtual Reality Visual Field Devices

Not Applicable

Completed

Conditions: Visual Field Defect, Paracentral Scotoma of Both Eyes
Visual Field Defect, Peripheral
Visual Field Defect, Nasal Step

Interventions: Other: VIrtual Reality Visual Field Exam

First Posted Date: 2021-03-08

Last Posted Date: 2021-03-08

Lead Sponsor: University of Miami

Target Recruit Count: 58

Registration Number: NCT04786886

Locations: 🇺🇸
Bascom Palmer Eye Institute, Miami, Florida, United States

PrEP at a Syringe Services Program

Phase 4

Completed

Conditions: Hiv
Substance Use Disorders

Interventions: Drug: Descovy 200Mg 25Mg Tablet
Behavioral: PrEP

First Posted Date: 2021-03-04

Last Posted Date: 2024-11-13

Lead Sponsor: University of Miami

Target Recruit Count: 90

Registration Number: NCT04782180

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy